Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Fair Value

Margin Of Safety %

Put/Call OI Ratio

0.32

Float Short​ %​

3.77

EPS 1 Diff

0.01

EPS Year Diff

0.08

Ticker: CERS




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2024-09-06CERS2.020.3510.004624
2024-09-09CERS1.9950.360.004654
2024-09-10CERS2.050.360.004656
2024-09-11CERS2.050.360.004656
2024-09-12CERS2.030.360.004658
2024-09-13CERS2.070.360.004659
2024-09-16CERS2.050.360.004660
2024-09-17CERS1.970.36999.994571
2024-09-18CERS1.790.370.004575
2024-09-19CERS1.820.370.004521
2024-09-20CERS1.80.370.064532
2024-09-23CERS1.780.3720.004526
2024-09-24CERS1.790.400.174631
2024-09-25CERS1.770.417.194713
2024-09-26CERS1.770.38999.994647
2024-09-27CERS1.740.380.004647
2024-09-30CERS1.7350.320.005260
2024-10-01CERS1.6950.321.885251
2024-10-02CERS1.690.320.005265
2024-10-03CERS1.6850.320.415266
2024-10-04CERS1.690.320.415266
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2024-09-06CERS2.0225.0- -0.13
2024-09-09CERS2.0125.0- -0.13
2024-09-10CERS2.0525.0- -0.13
2024-09-11CERS2.0625.0- -0.13
2024-09-12CERS2.0325.0- -0.13
2024-09-13CERS2.0625.0- -0.13
2024-09-16CERS2.0625.0- -0.13
2024-09-17CERS1.9825.0- -0.13
2024-09-18CERS1.7825.0- -0.13
2024-09-19CERS1.8225.0- -0.13
2024-09-20CERS1.8025.0- -0.13
2024-09-23CERS1.7725.0- -0.13
2024-09-24CERS1.7925.0- -0.13
2024-09-25CERS1.7725.0- -0.13
2024-09-26CERS1.7825.0- -0.13
2024-09-27CERS1.7525.0- -0.13
2024-09-30CERS1.7325.0- -0.13
2024-10-01CERS1.7025.0- -0.13
2024-10-02CERS1.6925.0- -0.13
2024-10-03CERS1.6925.0- -0.13
2024-10-04CERS1.7025.0- -0.13
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2024-09-06CERS-4.71-0.343.63
2024-09-09CERS-4.71-0.343.63
2024-09-10CERS-4.71-0.343.63
2024-09-11CERS-4.72-0.343.63
2024-09-12CERS-4.73-0.343.64
2024-09-13CERS-4.44-0.343.64
2024-09-16CERS-0.99-0.343.64
2024-09-17CERS-0.99-0.343.64
2024-09-18CERS-0.99-0.343.64
2024-09-19CERS-0.99-0.343.64
2024-09-20CERS-0.99-0.343.64
2024-09-23CERS-0.99-0.343.64
2024-09-24CERS-0.99-0.343.64
2024-09-25CERS-0.99-0.343.77
2024-09-26CERS-0.99-0.343.77
2024-09-27CERS-0.99-0.343.77
2024-09-30CERS-0.99-0.343.77
2024-10-01CERS-0.99-0.343.77
2024-10-02CERS-0.99-0.343.77
2024-10-03CERS-0.99-0.343.77
2024-10-04CERS-0.99-0.343.77
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.03

Avg. EPS Est. Current Quarter

-0.03

Avg. EPS Est. Next Quarter

-0.02

Insider Transactions

-0.99

Institutional Transactions

-0.34

Beta

1.19

Average Sales Estimate Current Quarter

45

Average Sales Estimate Next Quarter

48

Fair Value (Academic)

Quality Score

41

Growth Score

49

Sentiment Score

42

Actual DrawDown %

80.8

Max Drawdown 5-Year %

-85.4

Target Price

4.5

P/E

Forward P/E

PEG

P/S

1.85

P/B

6.36

P/Free Cash Flow

EPS

-0.13

Average EPS Est. Cur. Y​

-0.13

EPS Next Y. (Est.)

-0.07

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-14.15

Relative Volume

0.56

Return on Equity vs Sector %

-70.2

Return on Equity vs Industry %

-60.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Cerus Corporation
Sector: Healthcare
Industry: Medical Devices
Employees: 625
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.
stock quote shares CERS – Cerus Corporation Stock Price stock today
news today CERS – Cerus Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch CERS – Cerus Corporation yahoo finance google finance
stock history CERS – Cerus Corporation invest stock market
stock prices CERS premarket after hours
ticker CERS fair value insiders trading